Literature DB >> 3098493

Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?

F Bochner, J Lloyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3098493     DOI： 10.1042/cs0710625

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN： 0143-5221            Impact factor:   6.124


× No keyword cloud information.
  6 in total

1.  [Not Available].

Authors:  E Hackenthal
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

2.  Pharmacokinetics of low-dose oral modified release, soluble and intravenous aspirin in man, and effects on platelet function.

Authors:  F Bochner; D B Williams; P M Morris; D M Siebert; J V Lloyd
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Aspirin all round?

Authors:  M Orme
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30

4.  Development of neurological problems after lumbar puncture.

Authors:  I K Hart; I Bone; D M Hadley
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

Review 5.  Aspirin for myocardial infarction. Clinical pharmacokinetic considerations.

Authors:  F Bochner; J V Lloyd
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

6.  The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid.

Authors:  M L Taylor; N L Misso; G A Stewart; P J Thompson
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.